Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
Salmanton-García J, Wipfler P, Valle-Simón P, Merakou C, Kopsidas I, Bethe U, Steinbach A, Spivak O, Součková L, Mendonça MA, Koniordou M, Hellemans M, Frías-Iniesta J, Davis RJ, Barta I, Azzini AM, Askling HH, Argyropoulos CD, Álvarez-Barco E, Akova M, Bonten MMJ, Cohen-Kandli M, Cox RJ, Flisiak R, Husa P, Jancoriene L, Koscalova A, Launay O, Lundgren J, Mallon P, Marques L, Nauclér P, Ochando J, Pana ZD, Tacconelli E, Tóth K, Trelle S, van Damme P, Zaoutis TE, Zeitlinger M, Albus K, Stewart FA, Hofstraat SHI, Bruijning-Verhagen P, Cornely OA; VACCELERATE Consortium. Electronic address: [email protected]. Salmanton-García J, et al. Among authors: askling hh. Vaccine. 2023 Jun 13;41(26):3915-3922. doi: 10.1016/j.vaccine.2023.05.006. Epub 2023 May 18. Vaccine. 2023. PMID: 37210309 Free PMC article.
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium.
Poulimeneas D, Koniordou M, Kousi D, Merakou C, Kopsidas I, Tsopela GC, Argyropoulos CD, Themistocleous SC, Shiamakkides G, Constantinou M, Alexandrou A, Noula E, Nearchou A, Salmanton-García J, Stewart FA, Heringer S, Albus K, Álvarez-Barco E, Macken A, Di Marzo R, Luis C, Valle-Simón P, Askling HH, Hellemans M, Spivak O, Davis RJ, Azzini AM, Barta I, Součková L, Jancoriene L, Akova M, Mallon PWG, Olesen OF, Frias-Iniesta J, van Damme P, Tóth K, Cohen-Kandli M, Cox RJ, Husa P, Nauclér P, Marques L, Ochando J, Tacconelli E, Zeitlinger M, Cornely OA, Pana ZD, Zaoutis TE; VACCELERATE Consortium. Poulimeneas D, et al. Among authors: askling hh. Vaccines (Basel). 2023 Nov 29;11(12):1784. doi: 10.3390/vaccines11121784. Vaccines (Basel). 2023. PMID: 38140188 Free PMC article.
Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trial.
Jastorff A, Gymnopoulou E, Salas J, Merrall E, Buntinx E, Martin C, Askling HH, Schenkenberger I, Yuste AC, Smith W, Sotolongo R, Von Engelhardt C, Bastian AR, Comeaux C, Ligtenberg N, Callendret B, Heijnen E. Jastorff A, et al. Among authors: askling hh. Vaccine. 2025 Jan 1;43(Pt 1):126514. doi: 10.1016/j.vaccine.2024.126514. Epub 2024 Nov 12. Vaccine. 2025. PMID: 39536455 Free article. Clinical Trial.
Tick-borne co-infections in Europe: Clinical conundrums.
Sandelin LL, Askling HH. Sandelin LL, et al. Among authors: askling hh. New Microbes New Infect. 2023 Jun 7;53:101157. doi: 10.1016/j.nmni.2023.101157. eCollection 2023 Jun. New Microbes New Infect. 2023. PMID: 37359148 Free PMC article. No abstract available.
Streamlining malaria prevention recommendations for travellers: current and future approaches.
McGuinness SL, Veit O, Angelin M, Antonini P, Boecken G, Boering M, Bühler S, Calleri G, Éperon G, Flaherty G, Gossner C, Askling HH, Holmberg V, Kuenzli E, Landry P, Lefevre E, Libman M, Longley N, Maniewski-Kelner U, Neumayr A, Rapp C, Ridpath AD, Rodriguez-Valero N, Rosdahl A, Rosenbusch D, Rossanese A, Rothe C, Schlagenhauf P, Soentjens P, Staehelin C, Visser J, Visser L, Wagner A, Walker A, Wiedermann U, Wroczynska A, Hatz C. McGuinness SL, et al. Among authors: askling hh. J Travel Med. 2024 Dec 10;31(8):taae113. doi: 10.1093/jtm/taae113. J Travel Med. 2024. PMID: 39167759 No abstract available.
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial.
Platt HL, Bruno C, Buntinx E, Pelayo E, Garcia-Huidobro D, Barranco-Santana EA, Sjoberg F, Song JY, Grijalva CG, Orenstein WA, Morgan L, Fernsler D, Xu W, Waleed M, Li J, Buchwald UK; STRIDE-3 Study Group. Platt HL, et al. Lancet Infect Dis. 2024 Oct;24(10):1141-1150. doi: 10.1016/S1473-3099(24)00344-X. Epub 2024 Jul 1. Lancet Infect Dis. 2024. PMID: 38964361 Clinical Trial.
50 results